Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Human Papillomavirus-Related Cervical Carcinoma 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Specimen Handling 7 Human Papillomavirus Recombinant Vaccine nonavalent 6 Radiotherapy, Intensity-Modulated 5 Human Papillomavirus DNA Tests 5 Colposcopy 5 Cisplatin 5 Patient Navigation 3 Methods 3 Early Intervention, Educational 3 Carboplatin 3 human papillomavirus vaccine, L1 type 16, 18 2 epigallocatechin gallate 2 artesunic acid 2 artemisinin 2 Standard of Care 2 Practice Guidelines as Topic 2 Papillomavirus Vaccines 2 Mass Screening 2 Educational Status 2 Docetaxel 2 Cytological Techniques 2 Blood Specimen Collection 2 Biopsy 2 toripalimab 1 fludarabine phosphate 1 fludarabine 1 artenimol 1 aldesleukin 1 adacel 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Tetanus Toxoid × 1 year × Clear all

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡